Viewing Study NCT00755118


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-03-02 @ 5:01 PM
Study NCT ID: NCT00755118
Status: TERMINATED
Last Update Posted: 2015-10-07
First Post: 2008-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
Sponsor: University Hospital of Crete
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic colorectal cancer View
None Second line View
None Irinotecan View
None Cetuximab View
None Bevacizumab View